CVS Caremark names Helena Foulkes EVP, chief healthcare strategy and marketing officer
WOONSOCKET, R.I. — CVS Caremark has named Helena Foulkes, who is widely regarded as one of the most visionary marketers in modern drug store retailing, to the newly created position of EVP and chief healthcare strategy and marketing officer.
In the new role, Foulkes will bring together the company’s capabilities in enterprise branding, communications, community relations, charitable giving, healthcare-reform strategy, government relations and marketing into one integrated organization in an effort to deliver even better business results and stronger partnerships.
"Helena Foulkes is a highly regarded executive who, as chief marketing officer, led the launch of [such] innovative programs [as] ExtraCare, Maintenance Choice and Pharmacy Advisor in both our retail and pharmacy benefit management businesses," stated Larry Merlo, president and CEO of CVS Caremark. "That hands-on experience in delivering products and services to consumers and clients gives her the perfect background to allow CVS Caremark to deliver even better business results and strengthen key partnerships to do more to improve health care in the [United States]."
Building on her previous role as chief marketing executive of both retail pharmacy and the PBM, Foulkes brings insight from sales and operations into her new role to engage an even broader array of external stakeholders.
"For the past several years, CVS Caremark has been an active player in helping to reshape the healthcare system," Foulkes stated. "As we help consumers and clients adapt to the evolving healthcare system, it is important for us to bring together all of our capabilities to identify more innovative ways to improve pharmacy care delivery and help customers better manage costs. We will be aggressive in building stronger partnerships to maintain and build our leadership position in the industry."
Foulkes joined CVS Caremark in 1992 and has held positions of increasing responsibility in the retail pharmacy, PBM and corporate areas.
Catalyst, Walgreens move ahead with PBM acquisition
ROCKVILLE, Md. — Catalyst Health Solutions and Walgreens on Monday announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with Catalyst’s previously announced proposed acquisition of Walgreens Health Initiatives, the pharmacy benefit management subsidiary of Walgreens.
Completion of the proposed acquisition remains subject to other closing conditions. The companies continue to expect to complete the transaction in the first half of 2011.
Teva launches chewable birth control pill
NORTH WALES, Pa. — Teva Pharmaceuticals has launched a chewable birth control pill, the generic drug maker said Friday.
Teva announced the launch of Zeosa (norethindrone and ethinyl estradiol) tablets.
The drug is chemically equivalent to Warner Chilcott’s Femcon Fe tablets and is available in the 0.4 mg/0.035 mg strength.